Patents by Inventor Fernando Martin Diaz

Fernando Martin Diaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240009296
    Abstract: Self-amplifying RNA (saRNA) molecules encoding an influenza virus antigen and methods of use thereof are disclosed herein.
    Type: Application
    Filed: July 6, 2023
    Publication date: January 11, 2024
    Applicant: PFIZER INC.
    Inventors: Hui Cai, Ye Che, Fernando Martin Diaz, Raquel Munoz-Moreno, Alicia Solórzano Quijano, Chong Wang
  • Publication number: 20240000914
    Abstract: This invention relates generally to compositions for making C A Vectors and uses thereof.
    Type: Application
    Filed: October 29, 2021
    Publication date: January 4, 2024
    Inventors: Simon DELAGRAVE, Fernando Martin DIAZ, Jared David PITTS, Kevin James LEBO, Joseph Louis TIMPONA, Nicole Marie BOISVERT
  • Publication number: 20230279423
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of curons and uses thereof.
    Type: Application
    Filed: July 15, 2022
    Publication date: September 7, 2023
    Inventors: Avak Kahvejian, Erica Gabrielle Weinstein, Nicholas McCartney Plugis, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar
  • Publication number: 20230233671
    Abstract: The present disclosure relates to RNA molecules encoding a varicella zoster virus (VZV). The present disclosure further relates to compositions comprising the RNA molecules formulated in a lipid nanoparticle (RNA-LNP). The present disclosure further relates to the use of the RNA molecules, RNA-LNPs and compositions for the treatment or prevention of herpes zoster or shingles.
    Type: Application
    Filed: October 12, 2022
    Publication date: July 27, 2023
    Inventors: Eric Matthew Bennett, Fernando Martin Diaz, Philip Ralph Dormitzer, Kathrin Ute Jansen, Raquel Munoz-Moreno, Alicia Solorzano Quijano
  • Publication number: 20230048858
    Abstract: This invention relates generally to anellosomes and compositions and uses thereof.
    Type: Application
    Filed: December 12, 2019
    Publication date: February 16, 2023
    Inventors: Erica Gabrielle Weinstein, Avak Kahvejian, Simon Delagrave, Nathan Lawrence Yozwiak, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar, Ryan D. Tedstone, Jared David Pitts
  • Publication number: 20220362315
    Abstract: This invention relates generally to viral vectors and viral particles based on Anelloviruses, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.
    Type: Application
    Filed: June 21, 2022
    Publication date: November 17, 2022
    Inventors: Simon Delagrave, Fernando Martin Diaz, Avak Kahvejian, Kevin James Lebo, Dhananjay Maniklal Nawandar, Jared David Pitts, Ryan D. Tedstone, Erica Gabrielle Weinstein, Nathan Lawrence Yozwiak
  • Patent number: 11446344
    Abstract: This invention relates generally to viral vectors and viral particles based on Anelloviruses, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.
    Type: Grant
    Filed: September 29, 2021
    Date of Patent: September 20, 2022
    Assignee: FLAGSHIP PIONEERING INNOVATIONS V, INC.
    Inventors: Simon Delagrave, Fernando Martin Diaz, Avak Kahvejian, Kevin James Lebo, Dhananjay Maniklal Nawandar, Jared David Pitts, Ryan D. Tedstone, Erica Gabrielle Weinstein, Nathan Lawrence Yozwiak
  • Publication number: 20220073950
    Abstract: This invention relates generally to anellosomes and compositions and uses thereof.
    Type: Application
    Filed: December 12, 2019
    Publication date: March 10, 2022
    Inventors: Erica Gabrielle Weinstein, Avak Kahvejian, Simon Delagrave, Nathan Lawrence Yozwiak, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar, Ryan D. Tedstone, Jared David Pitts
  • Publication number: 20220042042
    Abstract: This invention relates generally to anellosomes and compositions and uses thereof.
    Type: Application
    Filed: December 12, 2019
    Publication date: February 10, 2022
    Inventors: Erica Gabrielle Weinstein, Avak Kahvejian, Simon Delagrave, Nathan Lawrence Yozwiak, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar, Ryan D. Tedstone, Jared David Pitts
  • Publication number: 20220040117
    Abstract: This invention relates generally to anellosomes and compositions and uses thereof.
    Type: Application
    Filed: December 12, 2019
    Publication date: February 10, 2022
    Inventors: Erica Gabrielle Weinstein, Avak Kahvejian, Simon Delagrave, Nathan Lawrence Yozwiak, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar, Ryan D. Tedstone, Jared David Pitts
  • Patent number: 11166996
    Abstract: This invention relates generally to viral vectors and viral particles based on Anelloviruses, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: November 9, 2021
    Assignee: FLAGSHIP PIONEERING INNOVATIONS V, INC.
    Inventors: Erica Gabrielle Weinstein, Avak Kahvejian, Simon Delagrave, Nathan Lawrence Yozwiak, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar, Ryan D. Tedstone, Jared David Pitts
  • Publication number: 20200385757
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of curons and uses thereof.
    Type: Application
    Filed: January 16, 2020
    Publication date: December 10, 2020
    Inventors: Avak Kahvejian, Erica Gabrielle Weinstein, Nicholas McCartney Plugis, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar
  • Publication number: 20200188456
    Abstract: This invention relates generally to viral vectors and viral particles based on Anelloviruses, which can be used to deliver an agent (e.g., an exogenous effector or an endogenous effector, e.g., a therapeutic effector) to a cell (e.g., a cell in a subject to be treated therapeutically). Described herein are anellosomes, anellovectors, and compositions and uses thereof.
    Type: Application
    Filed: June 21, 2019
    Publication date: June 18, 2020
    Inventors: Erica Gabrielle Weinstein, Avak Kahvejian, Simon Delagrave, Nathan Lawrence Yozwiak, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar, Ryan D. Tedstone, Jared David Pitts
  • Publication number: 20200123203
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of curons and uses thereof.
    Type: Application
    Filed: June 13, 2018
    Publication date: April 23, 2020
    Applicant: FLAGSHIP PIONEERING INNOVATIONS V, INC.
    Inventors: Avak Kahvejian, Erica Gabrielle Weinstein, Nicholas McCartney Plugis, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar
  • Publication number: 20190211361
    Abstract: This invention relates generally to pharmaceutical compositions and preparations of curons and uses thereof.
    Type: Application
    Filed: March 27, 2019
    Publication date: July 11, 2019
    Inventors: Avak Kahvejian, Erica Gabrielle Weinstein, Nicholas McCartney Plugis, Kevin James Lebo, Fernando Martin Diaz, Dhananjay Maniklal Nawandar